monjuvi
(Tafasitamab-cxix)MorphoSys US Inc.
Usage: MONJUVI, in combination with lenalidomide, is indicated for treating adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not eligible for autologous stem cell transplant. Approval is based on overall response rate and may require further verification of clinical benefit.